agn to take over nyr ... good acquisition
- Forums
- ASX - By Stock
- NYR
- Ann: Phase I Clinical Trial Dosing Update No 1
NYR
nyrada inc.
Add to My Watchlist
2.13%
!
24.0¢

Ann: Phase I Clinical Trial Dosing Update No 1, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $50.62M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.5¢ | $91.00K | 385.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 19882 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 28647 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 19882 | 0.235 |
3 | 81025 | 0.230 |
5 | 104147 | 0.225 |
4 | 201420 | 0.220 |
2 | 120005 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 28647 | 1 |
0.245 | 111702 | 2 |
0.250 | 26752 | 1 |
0.255 | 25000 | 1 |
0.260 | 154498 | 3 |
Last trade - 12.52pm 26/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online